IGF-1 LR3 1MG Research Peptide
Promotes muscle growth and lean mass development Enhances muscle recovery and repair Supports fat metabolism and body recomposition Improves nutrient uptake into muscle cells May increase strength, endurance, and workout performance Supports overall cellular growth and regeneration
IGF-1 LR3 1MG is a research peptide referenced in scientific literature as a synthetic analogue of insulin-like growth factor 1. This IGF-1 LR3 1MG product page provides educational, research-only information focused on compound structure, laboratory context, and non-clinical investigation.
Some peptides, including IGF-1 LR3, are synthetically created and can be derived from natural products, often designed as a combination of specific amino acid sequences to achieve targeted biological effects.
IGF-1 LR3 1MG is supplied by NuRev Peptides strictly for laboratory research and testing purposes. NuRev Peptides is a US-based supplier of high-purity research peptides primarily for laboratory use. All information presented here is neutral, factual, and intended to support scientific discussion rather than clinical, therapeutic, or diagnostic application. This compound is not intended for human or animal use.
NuRev Peptides is committed to quality and research integrity. Every batch is tested by independent third-party laboratories to ensure it exceeds 99% purity, and all products are produced in FDA-audited, cGMP-certified facilities. Each order includes a Certificate of Analysis (CoA) detailing product identity, method, and purity. NuRev stands out in the peptide market due to its clinical-grade manufacturing for research purposes and its focus on high purity, rigorous third-party verification, and research innovation in 2026. Researchers are encouraged to discover NuRev’s catalog, which includes specialized peptide compounds for weight and metabolism research, recovery and growth factors, and topical research.
Learn more about NuRev’s research peptides and laboratory solutions.
Scientific Background of IGF-1 LR3 1MG Peptides
IGF-1 LR3 1MG is structurally modified from native IGF-1 through an arginine substitution at position 3 and a 13–amino acid extension at the N-terminus. These modifications are discussed in research literature for their effect on reducing binding affinity to insulin-like growth factor binding proteins, resulting in extended biological half-life in experimental models.
In non-clinical research environments, IGF-1 LR3 is studied in relation to cellular growth signaling, anabolic pathway exploration, and metabolic signaling frameworks. Research discussions focus on receptor interaction dynamics, intracellular signaling cascades, and molecular behavior under controlled laboratory conditions. NuRev Peptides does not make claims regarding outcomes, efficacy, or safety related to this compound.
All information on this page is provided strictly for educational and research discussion purposes. This compound is not intended for diagnostic, therapeutic, medical, or veterinary use under any circumstances.
NuRev Peptides maintains a research-only policy and emphasizes transparency, documentation, and third-party laboratory verification where applicable.
Research-Only Use and Compliance Notice
All information on this page is provided strictly for educational and research discussion purposes. This compound is not intended for diagnostic, therapeutic, medical, or veterinary use under any circumstances.
NuRev Peptides maintains a research-only policy and emphasizes transparency, documentation, and third-party laboratory verification where applicable.
Additional scientific context related to compounds can be found through publicly available research databases such as PubChem.
For further information on purity please visit Certificates of Analysis.
To learn more about our research disclaimers please visit our page Research-only disclaimer.